医療美容のための再生注射の世界市場に関する洞察、2031年までの予測

当レポートは、医療美容のための再生注射 (Regenerative Injection for Medical Beauty) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• 医療美容のための再生注射の製品概要
• 市場：タイプ別
  • 世界の医療美容のための再生注射の市場規模成長率：タイプ別, 2020 VS 2024 VS 2031
  • PLLA
  • PDLLA
  • PCL
  • Hydroxyapatite
• 市場：用途別
  • 世界の医療美容のための再生注射の市場規模成長率：用途別, 2020 VS 2024 VS 2031
  • Medical Beauty Institution
  • Hospital
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界の医療美容のための再生注射の収益 推定および予測 2020-2031
• 世界の収益：地域別
  • 世界の医療美容のための再生注射 収益：地域別: 2020 VS 2024 VS 2031
  • 世界の医療美容のための再生注射 収益：地域別 (2020-2031)
  • 世界の医療美容のための再生注射の収益市場シェア 地域別 (2020-2031)
• 世界の医療美容のための再生注射 売上予測・予想 2020-2031
• 世界の販売：地域別
  • 世界の医療美容のための再生注射 販売：地域別: 2020 VS 2024 VS 2031
  • 世界の医療美容のための再生注射 販売：地域別 (2020-2031)
  • 世界の医療美容のための再生注射の販売市場シェア 地域別 (2020-2031)
• 米国・カナダ
• 欧州
• 中国
• アジア（中国を除く）
• 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

• 世界の販売：企業別
  • 世界の医療美容のための再生注射 販売：企業別 (2020-2025)
  • 世界の医療美容のための再生注射の販売市場シェア：企業別 (2020-2025)
  • 世界の上位10・上位5企業： 医療美容のための再生注射 2024年
• 世界の収益：企業別
  • 世界の医療美容のための再生注射 収益：企業別 (2020-2025)
  • 世界の医療美容のための再生注射の収益市場シェア：企業別 (2020-2025)
  • 世界の上位10・上位5企業： 医療美容のための再生注射 収益 2024年
• 世界の主要企業 医療美容のための再生注射, 業界ランキング, 2023 VS 2024
• 世界の医療美容のための再生注射の販売価格：企業別 (2020-2025)
• 競合情勢の分析
  • 企業の市場集中度 (CR5 and HHI)
  • 世界の医療美容のための再生注射の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要メーカー 医療美容のための再生注射, 製造拠点分布と本社
• 世界の主要メーカー 医療美容のための再生注射, 提供製品と用途
• 世界の主要メーカー 医療美容のための再生注射, 業界参入時期
• M&A, 拡張計画

第4章 市場規模：タイプ別

• 世界の販売：タイプ別
  • 世界の医療美容のための再生注射の販売実績：タイプ別 (2020-2025)
  • 世界の医療美容のための再生注射の販売予測：タイプ別 (2026-2031)
  • 世界の医療美容のための再生注射の販売市場シェア：タイプ別 (2020-2031)
• 世界の収益：タイプ別
  • 世界の医療美容のための再生注射の収益実績：タイプ別 (2020-2025)
  • 世界の医療美容のための再生注射の収益予測：タイプ別 (2026-2031)
  • 世界の医療美容のための再生注射の収益市場シェア：タイプ別 (2020-2031)
• 世界の価格：タイプ別
  • 世界の医療美容のための再生注射 価格：タイプ別 (2020-2025)
  • 世界の医療美容のための再生注射の価格予測：タイプ別 (2026-2031)

第5章 市場規模：用途別

• 世界の販売：用途別
  • 世界の医療美容のための再生注射の販売実績：用途別 (2020-2025)
  • 世界の医療美容のための再生注射の販売予測：用途別 (2026-2031)
  • 世界の医療美容のための再生注射の販売市場シェア：用途別 (2020-2031)
• 世界の収益：用途別
  • 世界の医療美容のための再生注射の収益実績：用途別 (2020-2025)
  • 世界の医療美容のための再生注射の収益予測：用途別 (2026-2031)
  • 世界の医療美容のための再生注射の収益市場シェア：用途別 (2020-2031)
• 世界の価格：用途別
  • 世界の医療美容のための再生注射 価格：用途別 (2020-2025)
  • 世界の医療美容のための再生注射の価格予測：用途別 (2026-2031)

第6章 米国・カナダ

• 米国・カナダ 市場規模：タイプ別
  • 米国・カナダ 医療美容のための再生注射 販売：タイプ別 (2020-2031)
  • 米国・カナダ 医療美容のための再生注射 収益：タイプ別 (2020-2031)
• 米国・カナダ 市場規模：用途別
  • 米国・カナダ 医療美容のための再生注射 販売：用途別 (2020-2031)
  • 米国・カナダ 医療美容のための再生注射 収益：用途別 (2020-2031)
• 米国・カナダ 市場規模：国別
  • 米国・カナダ 医療美容のための再生注射の収益：国別: 2020 VS 2024 VS 2031
  • 米国・カナダ 医療美容のための再生注射の収益：国別 (2020-2031)
  • 米国・カナダ 医療美容のための再生注射の販売：国別 (2020-2031)
  • US
  • カナダ

第7章 欧州

• 欧州の市場規模：タイプ別
  • 欧州の医療美容のための再生注射 販売：タイプ別 (2020-2031)
  • 欧州の医療美容のための再生注射 収益：タイプ別 (2020-2031)
• 欧州の市場規模：用途別
  • 欧州の医療美容のための再生注射 販売：用途別 (2020-2031)
  • 欧州の医療美容のための再生注射 収益：用途別 (2020-2031)
• 欧州の市場規模：国別
  • 欧州の医療美容のための再生注射の収益：国別: 2020 VS 2024 VS 2031
  • 欧州の医療美容のための再生注射の販売：国別 (2020-2031)
  • 欧州の医療美容のための再生注射の収益：国別 (2020-2031)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 中国

• 中国の市場規模：タイプ別
  • 中国の医療美容のための再生注射 販売：タイプ別 (2020-2031)
  • 中国の医療美容のための再生注射 収益：タイプ別 (2020-2031)
• 中国の市場規模：用途別
  • 中国の医療美容のための再生注射 販売：用途別 (2020-2031)
  • 中国の医療美容のための再生注射 収益：用途別 (2020-2031)

第9章 アジア（中国を除く）

• アジア地域 市場規模：タイプ別
  • アジア地域 医療美容のための再生注射 販売：タイプ別 (2020-2031)
  • アジア地域 医療美容のための再生注射 収益：タイプ別 (2020-2031)
• アジア地域 市場規模：用途別
  • アジア地域 医療美容のための再生注射 販売：用途別 (2020-2031)
  • アジア地域 医療美容のための再生注射 収益：用途別 (2020-2031)
• アジア地域 市場規模：地域別
  • アジア地域 医療美容のための再生注射 収益：地域別: 2020 VS 2024 VS 2031
  • アジア地域 医療美容のための再生注射 収益：地域別 (2020-2031)
  • アジア地域 医療美容のための再生注射 販売：地域別 (2020-2031)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

• 中東, アフリカ ・ラテンアメリカの市場規模：タイプ別
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射 販売：タイプ別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射 収益：タイプ別 (2020-2031)
• 中東, アフリカ ・ラテンアメリカの市場規模：用途別
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射 販売：用途別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射 収益：用途別 (2020-2031)
• 中東, アフリカ ・ラテンアメリカの市場規模：国別
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射の収益：国別: 2020 VS 2024 VS 2031
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射の収益：国別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの医療美容のための再生注射の販売：国別 (2020-2031)
  • ブラジル
  • メキシコ
  • トルコ
  • イスラエル
  • 湾岸協力理事会諸国

第11章 企業プロファイル

• Aimeike Biotech
• Shengboma Biological Materials
• Huadong Medicine
• Jiangsu Wuzhong
• Galderma
• DERMA VEIL
• Merz Aesthetics
• Regen Biotech
• PRP SCIENCE

第12章 業界チェーンと販売チャネルの分析

• 医療美容のための再生注射 業界チェーン分析
• 医療美容のための再生注射 主要原材料
  • 主要原材料
  • 原材料の主要サプライヤー
• 医療美容のための再生注射 生産形態とプロセス
• 医療美容のための再生注射 販売およびマーケティング
  • 医療美容のための再生注射 販売チャネルs
  • 医療美容のための再生注射 卸業者
• 医療美容のための再生注射 顧客

第13章 医療美容のための再生注射 市場動向

• 医療美容のための再生注射 業界動向
• 医療美容のための再生注射 市場の促進要因
• 医療美容のための再生注射 市場の課題
• 医療美容のための再生注射 市場の抑制要因

第14章 主な調査結果 世界の医療美容のための再生注射の主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Regenerative Injection for Medical Beauty Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of PLLA

Table 3. Major Manufacturers of PDLLA

Table 4. Major Manufacturers of PCL

Table 5. Major Manufacturers of Hydroxyapatite

Table 6. Global Regenerative Injection for Medical Beauty Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 7. Global Regenerative Injection for Medical Beauty Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 8. Global Revenue by Region (2020-2025) & (US$ Million)

Table 9. Global Revenue Market Share by Region (2020-2031)

Table 10. Global Regenerative Injection for Medical Beauty Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 11. Global Regenerative Injection for Medical Beauty Sales by Region (2020-2031) & (K Units)

Table 12. Global Sales Market Share by Region (2020-2031)

Table 13. Global Regenerative Injection for Medical Beauty Sales by Manufacturers (2020-2025) & (K Units)

Table 14. Global Regenerative Injection for Medical Beauty Sales Share by Manufacturers (2020-2025)

Table 15. Global Regenerative Injection for Medical Beauty Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Regenerative Injection for Medical Beauty Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Players of Regenerative Injection for Medical Beauty, Industry Ranking, 2023 VS 2024 VS 2024

Table 18. Regenerative Injection for Medical Beauty Price by Manufacturers (2020-2025) & (US$/Unit)

Table 19. Global Regenerative Injection for Medical Beauty Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Regenerative Injection for Medical Beauty by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Injection for Medical Beauty as of 2024)

Table 21. Global Key Manufacturers of Regenerative Injection for Medical Beauty, Manufacturing Base Distribution and Headquarters

Table 22. Global Key Manufacturers of Regenerative Injection for Medical Beauty, Product Offered and Application

Table 23. Global Key Manufacturers of Regenerative Injection for Medical Beauty, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Regenerative Injection for Medical Beauty Sales by Type (2020-2025) & (K Units)

Table 26. Global Regenerative Injection for Medical Beauty Sales by Type (2026-2031) & (K Units)

Table 27. Global Sales Share by Type (2020-2031)

Table 28. Global Regenerative Injection for Medical Beauty Revenue by Type (2020-2025) & (US$ Million)

Table 29. Global Regenerative Injection for Medical Beauty Revenue by Type (2026-2031) & (US$ Million)

Table 30. Global Revenue Share by Type (2020-2031)

Table 31. Regenerative Injection for Medical Beauty Price by Type (2020-2025) & (US$/Unit)

Table 32. Global Regenerative Injection for Medical Beauty Price Forecast by Type (2026-2031) & (US$/Unit)

Table 33. Global Regenerative Injection for Medical Beauty Sales by Application (2020-2025) & (K Units)

Table 34. Global Regenerative Injection for Medical Beauty Sales by Application (2026-2031) & (K Units)

Table 35. Global Sales Share by Application (2020-2031)

Table 36. Global Regenerative Injection for Medical Beauty Revenue by Application (2020-2025) & (US$ Million)

Table 37. Global Regenerative Injection for Medical Beauty Revenue by Application (2026-2031) & (US$ Million)

Table 38. Global Revenue Share by Application (2020-2031)

Table 39. Regenerative Injection for Medical Beauty Price by Application (2020-2025) & (US$/Unit)

Table 40. Global Regenerative Injection for Medical Beauty Price Forecast by Application (2026-2031) & (US$/Unit)

Table 41. US & Canada Sales by Type (2020-2031) & (K Units)

Table 42. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 43. US & Canada Sales by Application (2020-2031) & (K Units)

Table 44. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 45. US & Canada Regenerative Injection for Medical Beauty Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 47. US & Canada Sales by Country (2020-2031) & (K Units)

Table 48. Europe Sales by Type (2020-2031) & (K Units)

Table 49. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 50. Europe Sales by Application (2020-2031) & (K Units)

Table 51. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 52. Europe Regenerative Injection for Medical Beauty Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 53. Europe Sales by Country (2020-2031) & (K Units)

Table 54. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 55. China Sales by Type (2020-2031) & (K Units)

Table 56. China Revenue by Type (2020-2031) & (US$ Million)

Table 57. China Sales by Application (2020-2031) & (K Units)

Table 58. China Revenue by Application (2020-2031) & (US$ Million)

Table 59. Asia Sales by Type (2020-2031) & (K Units)

Table 60. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 61. Asia Sales by Application (2020-2031) & (K Units)

Table 62. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 63. Asia Regenerative Injection for Medical Beauty Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 64. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 65. Asia Sales by Region (2020-2031) & (K Units)

Table 66. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 69. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 71. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 72. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 73. Aimeike Biotech Company Information

Table 74. Aimeike Biotech Description and Major Businesses

Table 75. Aimeike Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 76. Aimeike Biotech Product Model Numbers, Pictures, Descriptions and Specifications

Table 77. Aimeike Biotech Recent Developments

Table 78. Shengboma Biological Materials Company Information

Table 79. Shengboma Biological Materials Description and Major Businesses

Table 80. Shengboma Biological Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Shengboma Biological Materials Product Model Numbers, Pictures, Descriptions and Specifications

Table 82. Shengboma Biological Materials Recent Developments

Table 83. Huadong Medicine Company Information

Table 84. Huadong Medicine Description and Major Businesses

Table 85. Huadong Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 86. Huadong Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 87. Huadong Medicine Recent Developments

Table 88. Jiangsu Wuzhong Company Information

Table 89. Jiangsu Wuzhong Description and Major Businesses

Table 90. Jiangsu Wuzhong Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 91. Jiangsu Wuzhong Product Model Numbers, Pictures, Descriptions and Specifications

Table 92. Jiangsu Wuzhong Recent Developments

Table 93. Galderma Company Information

Table 94. Galderma Description and Major Businesses

Table 95. Galderma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 96. Galderma Product Model Numbers, Pictures, Descriptions and Specifications

Table 97. Galderma Recent Developments

Table 98. DERMA VEIL Company Information

Table 99. DERMA VEIL Description and Major Businesses

Table 100. DERMA VEIL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 101. DERMA VEIL Product Model Numbers, Pictures, Descriptions and Specifications

Table 102. DERMA VEIL Recent Developments

Table 103. Merz Aesthetics Company Information

Table 104. Merz Aesthetics Description and Major Businesses

Table 105. Merz Aesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 106. Merz Aesthetics Product Model Numbers, Pictures, Descriptions and Specifications

Table 107. Merz Aesthetics Recent Developments

Table 108. Regen Biotech Company Information

Table 109. Regen Biotech Description and Major Businesses

Table 110. Regen Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 111. Regen Biotech Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Regen Biotech Recent Developments

Table 113. PRP SCIENCE Company Information

Table 114. PRP SCIENCE Description and Major Businesses

Table 115. PRP SCIENCE Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 116. PRP SCIENCE Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. PRP SCIENCE Recent Developments

Table 118. Key Raw Materials Lists

Table 119. Raw Materials Key Suppliers Lists

Table 120. Distributors List

Table 121. Customers List

Table 122. Market Trends

Table 123. Market Drivers

Table 124. Market Challenges

Table 125. Market Restraints

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Regenerative Injection for Medical Beauty Product Picture

Figure 2. Global Regenerative Injection for Medical Beauty Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Regenerative Injection for Medical Beauty Market Share by Type: 2024 & 2031

Figure 4. PLLA Product Picture

Figure 5. PDLLA Product Picture

Figure 6. PCL Product Picture

Figure 7. Hydroxyapatite Product Picture

Figure 8. Global Regenerative Injection for Medical Beauty Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Global Regenerative Injection for Medical Beauty Market Share by Application: 2024 & 2031

Figure 10. Medical Beauty Institution

Figure 11. Hospital

Figure 12. Others

Figure 13. Regenerative Injection for Medical Beauty Report Years Considered

Figure 14. Global Regenerative Injection for Medical Beauty Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 16. Global Regenerative Injection for Medical Beauty Revenue by Region (2020-2031) (US$ Million)

Figure 17. Global Regenerative Injection for Medical Beauty Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 18. Global Regenerative Injection for Medical Beauty Revenue Market Share by Region (2020-2031)

Figure 19. Global Regenerative Injection for Medical Beauty Sales (2020-2031) & (K Units)

Figure 20. Global Regenerative Injection for Medical Beauty Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 21. Global Regenerative Injection for Medical Beauty Sales Market Share by Region (2020-2031)

Figure 22. US & Canada Regenerative Injection for Medical Beauty Sales YoY (2020-2031) & (K Units)

Figure 23. US & Canada Regenerative Injection for Medical Beauty Revenue YoY (2020-2031) & (US$ Million)

Figure 24. Europe Regenerative Injection for Medical Beauty Sales YoY (2020-2031) & (K Units)

Figure 25. Europe Regenerative Injection for Medical Beauty Revenue YoY (2020-2031) & (US$ Million)

Figure 26. China Regenerative Injection for Medical Beauty Sales YoY (2020-2031) & (K Units)

Figure 27. China Regenerative Injection for Medical Beauty Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Asia (excluding China) Regenerative Injection for Medical Beauty Sales YoY (2020-2031) & (K Units)

Figure 29. Asia (excluding China) Regenerative Injection for Medical Beauty Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales YoY (2020-2031) & (K Units)

Figure 31. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Global Regenerative Injection for Medical Beauty Sales Share by Manufacturers (2024)

Figure 33. The Regenerative Injection for Medical Beauty Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 34. Global Regenerative Injection for Medical Beauty Revenue Share by Manufacturers (2024)

Figure 35. The Top 5 and 10 Largest Manufacturers of Regenerative Injection for Medical Beauty in the World: Market Share by Regenerative Injection for Medical Beauty Revenue in 2024

Figure 36. Global Regenerative Injection for Medical Beauty Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Global Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)

Figure 38. Global Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)

Figure 39. Global Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)

Figure 40. Global Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)

Figure 41. US & Canada Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)

Figure 42. US & Canada Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)

Figure 43. US & Canada Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)

Figure 44. US & Canada Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)

Figure 45. US & Canada Regenerative Injection for Medical Beauty Revenue Share by Country (2020-2031)

Figure 46. US & Canada Regenerative Injection for Medical Beauty Sales Share by Country (2020-2031)

Figure 47. US Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 48. Canada Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 49. Europe Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)

Figure 50. Europe Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)

Figure 51. Europe Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)

Figure 52. Europe Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)

Figure 53. Europe Regenerative Injection for Medical Beauty Sales Share by Country (2020-2031)

Figure 54. Europe Regenerative Injection for Medical Beauty Revenue Share by Country (2020-2031)

Figure 55. Germany Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 56. France Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 57. U.K. Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 58. Italy Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 59. Russia Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 60. China Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)

Figure 61. China Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)

Figure 62. China Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)

Figure 63. China Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)

Figure 64. Asia Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)

Figure 65. Asia Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)

Figure 66. Asia Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)

Figure 67. Asia Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)

Figure 68. Asia Regenerative Injection for Medical Beauty Revenue Share by Region (2020-2031)

Figure 69. Asia Regenerative Injection for Medical Beauty Sales Share by Region (2020-2031)

Figure 70. Japan Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 71. South Korea Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 72. China Taiwan Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 73. Southeast Asia Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 74. India Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 75. Australia Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 76. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)

Figure 77. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)

Figure 78. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)

Figure 79. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)

Figure 80. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue Share by Country (2020-2031)

Figure 81. Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales Share by Country (2020-2031)

Figure 82. Brazil Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 83. Mexico Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 84. Turkey Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 85. Israel Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 86. GCC Countries Regenerative Injection for Medical Beauty Revenue (2020-2031) & (US$ Million)

Figure 87. Value Chain

Figure 88. Regenerative Injection for Medical Beauty Production Process

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

This research report focuses on the Regenerative Injection for Medical Beauty Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Regenerative Injection for Medical Beauty Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Regenerative Injection for Medical Beauty Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 PLLA
  • 1.2.3 PDLLA
  • 1.2.4 PCL
  • 1.2.5 Hydroxyapatite
• 1.3 Market by Application
  • 1.3.1 Global Regenerative Injection for Medical Beauty Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Medical Beauty Institution
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Regenerative Injection for Medical Beauty Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Regenerative Injection for Medical Beauty Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Regenerative Injection for Medical Beauty Revenue by Region (2020-2031)
  • 2.2.3 Global Regenerative Injection for Medical Beauty Revenue Market Share by Region (2020-2031)
• 2.3 Global Regenerative Injection for Medical Beauty Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Regenerative Injection for Medical Beauty Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Regenerative Injection for Medical Beauty Sales by Region (2020-2031)
  • 2.4.3 Global Regenerative Injection for Medical Beauty Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Regenerative Injection for Medical Beauty Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Regenerative Injection for Medical Beauty Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Regenerative Injection for Medical Beauty in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Regenerative Injection for Medical Beauty Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Regenerative Injection for Medical Beauty Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Regenerative Injection for Medical Beauty Revenue in 2024
• 3.3 Global Key Players of Regenerative Injection for Medical Beauty, Industry Ranking, 2023 VS 2024
• 3.4 Global Regenerative Injection for Medical Beauty Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Regenerative Injection for Medical Beauty Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Regenerative Injection for Medical Beauty, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Regenerative Injection for Medical Beauty, Product Offered and Application
• 3.8 Global Key Manufacturers of Regenerative Injection for Medical Beauty, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Regenerative Injection for Medical Beauty Historical Sales by Type (2020-2025)
  • 4.1.2 Global Regenerative Injection for Medical Beauty Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Regenerative Injection for Medical Beauty Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Regenerative Injection for Medical Beauty Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Regenerative Injection for Medical Beauty Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Regenerative Injection for Medical Beauty Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Regenerative Injection for Medical Beauty Price by Type (2020-2025)
  • 4.3.2 Global Regenerative Injection for Medical Beauty Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Regenerative Injection for Medical Beauty Historical Sales by Application (2020-2025)
  • 5.1.2 Global Regenerative Injection for Medical Beauty Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Regenerative Injection for Medical Beauty Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Regenerative Injection for Medical Beauty Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Regenerative Injection for Medical Beauty Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Regenerative Injection for Medical Beauty Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Regenerative Injection for Medical Beauty Price by Application (2020-2025)
  • 5.3.2 Global Regenerative Injection for Medical Beauty Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Regenerative Injection for Medical Beauty Sales by Type (2020-2031)
  • 6.1.2 US & Canada Regenerative Injection for Medical Beauty Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Regenerative Injection for Medical Beauty Sales by Application (2020-2031)
  • 6.2.2 US & Canada Regenerative Injection for Medical Beauty Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Regenerative Injection for Medical Beauty Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Regenerative Injection for Medical Beauty Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Regenerative Injection for Medical Beauty Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Regenerative Injection for Medical Beauty Sales by Type (2020-2031)
  • 7.1.2 Europe Regenerative Injection for Medical Beauty Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Regenerative Injection for Medical Beauty Sales by Application (2020-2031)
  • 7.2.2 Europe Regenerative Injection for Medical Beauty Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Regenerative Injection for Medical Beauty Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Regenerative Injection for Medical Beauty Sales by Country (2020-2031)
  • 7.3.3 Europe Regenerative Injection for Medical Beauty Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Regenerative Injection for Medical Beauty Sales by Type (2020-2031)
  • 8.1.2 China Regenerative Injection for Medical Beauty Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Regenerative Injection for Medical Beauty Sales by Application (2020-2031)
  • 8.2.2 China Regenerative Injection for Medical Beauty Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Regenerative Injection for Medical Beauty Sales by Type (2020-2031)
  • 9.1.2 Asia Regenerative Injection for Medical Beauty Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Regenerative Injection for Medical Beauty Sales by Application (2020-2031)
  • 9.2.2 Asia Regenerative Injection for Medical Beauty Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Regenerative Injection for Medical Beauty Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Regenerative Injection for Medical Beauty Revenue by Region (2020-2031)
  • 9.3.3 Asia Regenerative Injection for Medical Beauty Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Regenerative Injection for Medical Beauty Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Aimeike Biotech
  • 11.1.1 Aimeike Biotech Company Information
  • 11.1.2 Aimeike Biotech Overview
  • 11.1.3 Aimeike Biotech Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Aimeike Biotech Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Aimeike Biotech Recent Developments
• 11.2 Shengboma Biological Materials
  • 11.2.1 Shengboma Biological Materials Company Information
  • 11.2.2 Shengboma Biological Materials Overview
  • 11.2.3 Shengboma Biological Materials Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 Shengboma Biological Materials Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Shengboma Biological Materials Recent Developments
• 11.3 Huadong Medicine
  • 11.3.1 Huadong Medicine Company Information
  • 11.3.2 Huadong Medicine Overview
  • 11.3.3 Huadong Medicine Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Huadong Medicine Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Huadong Medicine Recent Developments
• 11.4 Jiangsu Wuzhong
  • 11.4.1 Jiangsu Wuzhong Company Information
  • 11.4.2 Jiangsu Wuzhong Overview
  • 11.4.3 Jiangsu Wuzhong Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Jiangsu Wuzhong Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Jiangsu Wuzhong Recent Developments
• 11.5 Galderma
  • 11.5.1 Galderma Company Information
  • 11.5.2 Galderma Overview
  • 11.5.3 Galderma Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 Galderma Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Galderma Recent Developments
• 11.6 DERMA VEIL
  • 11.6.1 DERMA VEIL Company Information
  • 11.6.2 DERMA VEIL Overview
  • 11.6.3 DERMA VEIL Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 DERMA VEIL Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 DERMA VEIL Recent Developments
• 11.7 Merz Aesthetics
  • 11.7.1 Merz Aesthetics Company Information
  • 11.7.2 Merz Aesthetics Overview
  • 11.7.3 Merz Aesthetics Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.4 Merz Aesthetics Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Merz Aesthetics Recent Developments
• 11.8 Regen Biotech
  • 11.8.1 Regen Biotech Company Information
  • 11.8.2 Regen Biotech Overview
  • 11.8.3 Regen Biotech Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.4 Regen Biotech Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Regen Biotech Recent Developments
• 11.9 PRP SCIENCE
  • 11.9.1 PRP SCIENCE Company Information
  • 11.9.2 PRP SCIENCE Overview
  • 11.9.3 PRP SCIENCE Regenerative Injection for Medical Beauty Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.4 PRP SCIENCE Regenerative Injection for Medical Beauty Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 PRP SCIENCE Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Regenerative Injection for Medical Beauty Industry Chain Analysis
• 12.2 Regenerative Injection for Medical Beauty Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Regenerative Injection for Medical Beauty Production Mode & Process
• 12.4 Regenerative Injection for Medical Beauty Sales and Marketing
  • 12.4.1 Regenerative Injection for Medical Beauty Sales Channels
  • 12.4.2 Regenerative Injection for Medical Beauty Distributors
• 12.5 Regenerative Injection for Medical Beauty Customers

13 Regenerative Injection for Medical Beauty Market Dynamics

• 13.1 Regenerative Injection for Medical Beauty Industry Trends
• 13.2 Regenerative Injection for Medical Beauty Market Drivers
• 13.3 Regenerative Injection for Medical Beauty Market Challenges
• 13.4 Regenerative Injection for Medical Beauty Market Restraints

14 Key Findings in the Global Regenerative Injection for Medical Beauty Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer